Page 417 - IJB-9-6

International Journal of Bioprinting Biofabrication for islet transplantation

Alchemist Project 1415180884 (20012378, Development 9. Marfil‐Garza BA, Shapiro AMJ, Kin T, 2021, Clinical islet
of Meta Soft Organ Module Manufacturing Technology transplantation: Current progress and new frontiers.
without Immunity Rejection and Module Assembly Robot J Hepatobiliary Pancreat Sci, 28(3): 243–254.
System) funded by the Ministry of Trade, Industry & 10. Schuetz C, Anazawa T, Cross SE, et al., 2018, β cell
Energy (MOTIE, Republic of Korea). replacement therapy. Transplantation, 102(2): 215–229.
11. Cantarelli E, Piemonti L, 2011, Alternative transplantation
Conflict of interest sites for pancreatic islet grafts. Curr Diab Rep, 11(5):
The authors declare no conflicts of interests. 364–374.
12. Sakata N, Tan A, Chan N, et al., 2009, Efficacy comparison
Author contributions between intraportal and subcapsular islet transplants in a
murine diabetic model. Transplant Proc, 41(1): 346–349.
Conceptualization: Dayoon Kang, Jaewook Kim, Jinah Jang
Supervision: Jinah Jang 13. Shi Y, Zhao YZ, Jiang Z, et al., 2022, Immune-protective
Writing – original draft: Dayoon Kang, Jaewook Kim formulations and process strategies for improved survival and
Writing – review & editing: Jinah Jang function of transplanted islets. Front Immunol, 13, 923241.
14. Yoshihara E, O’Connor C, Gasser E, et al., 2020, Immune-
Ethics approval and consent to participate evasive human islet-like organoids ameliorate diabetes.
Nature, 586(7830): 606–611.
Not applicable.
15. Liang JP, Accolla RP, Soundirarajan M, et al., 2021,
Consent for publication Engineering a macroporous oxygen-generating scaffold for
enhancing islet cell transplantation within an extrahepatic
Not applicable. site. Acta Biomater, 130: 268–280.
16. Chow LW, Wang L jia, Kaufman DB, et al., 2010, Self-
Availability of data assembling nanostructures to deliver angiogenic factors to
Not applicable. pancreatic islets. Biomaterials, 31(24): 6154–6161.
17. Sigrist S, Mechine-Neuville A, Mandes K, et al., 2003,
References Influence of VEGF on the viability of encapsulated
pancreatic rat islets after transplantation in diabetic mice.
1. Alwafi H, Alsharif AA, Wei L, et al., 2020, Incidence and Cell Transplant, 12(6): 627–635.
prevalence of hypoglycaemia in type 1 and type 2 diabetes 18. Zhang N, Richter A, Suriawinata J, et al., 2004, Elevated
individuals: A systematic review and meta-analysis. Diabetes vascular endothelial growth factor production in islets
Res Clin Pract, 170: 108522.
improves islet graft vascularization. Diabetes, 53(4): 963–970.
2. Shapiro AMJ, Lakey JRT, Ryan EA, et al., 2000, Islet 19. Verseijden F, Posthumus-van Sluijs SJ, van Neck JW,
transplantation in seven patients with Type 1 diabetes et al., 2012, Vascularization of prevascularized and non-
mellitus using a glucocorticoid-free immunosuppressive prevascularized fibrin-based human adipose tissue
regimen. N Engl J Med, 343(4): 230–238.
constructs after implantation in nude mice. J Tissue Eng
3. Merani S, Shapiro AMJ, 2006, Current status of pancreatic Regen Med, 6(3): 169–178.
islet transplantation. Clin Sci, 110(6): 611–625.
20. Vlahos AE, Kinney SM, Kingston BR, et al., 2020,
4. Shapiro AMJ, Pokrywczynska M, Ricordi C, 2017, Clinical Endothelialized collagen based pseudo-islets enables
pancreatic islet transplantation. Nat Rev Endocrinol, 13(5): tuneable subcutaneous diabetes therapy. Biomaterials, 232:
268–277. 119710.
5. Vantyghem MC, de Koning EJP, Pattou F, et al., 2019, 21. Gupta R, Sefton M V., 2011, Application of an endothelialized
Advances in β-cell replacement therapy for the treatment of modular construct for islet transplantation in syngeneic and
type 1 diabetes. The Lancet, 394(10205): 1274–1285. allogeneic immunosuppressed rat models. Tissue Eng Part
A, 17(15–16): 2005–2015.
6. Jansson L, Carlsson PO, 2002, Graft vascular function after
transplantation of pancreatic islets. Diabetologia, 45(6): 749–763. 22. Vlahos AE, Cober N, Sefton MV, 2017, Modular tissue
engineering for the vascularization of subcutaneously
7. Zhang N, Su D, Qu S, et al., 2006, Sirolimus is associated
with reduced islet engraftment and impaired β-cell function. transplanted pancreatic islets. Proc Natl Acad Sci, 114(35):
Diabetes, 55(9): 2429–2436. 9337–9342.
23. Stendahl JC, Kaufman DB, Stupp SI, 2009, Extracellular
8. Kim JE, Kim SH, Jung Y, 2016, Current status of three- matrix in pancreatic islets: Relevance to scaffold design and
dimensional printing inks for soft tissue regeneration. Tissue transplantation. Cell Transplant, 18(1): 1–12.
Eng Regen Med, 13(6): 636–646.

Volume 9 Issue 6 (2023) 409 https://doi.org/10.36922/ijb.1024